La Jolla Pharmaceutical Company
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, La Jolla Pharmaceutical Company sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).
La Jolla Pharmaceutical Company: 12 sponsored US clinical trials, none currently recruiting.
La Jolla Pharmaceutical Company sponsors 12 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. 3 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage).
Top-decile sponsor footprint
La Jolla Pharmaceutical Company ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
8 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (66.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
12 total, page 1 of 1
A Study of LJPC-501 in Pediatric Patients With Hypotension
NCT03431077
A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Patients With Transfusion-Dependent Beta Thalassemia
NCT03381833
A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis
NCT03395704
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
NCT02338843
A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome
NCT01906307
A Phase 2 Extension Study of Study GCS-100-CS-4002
NCT02155673
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
NCT01843790
Safety Study of GCS-100 to Treat Chronic Kidney Disease
NCT01717248
Safety and Efficacy Study of GCS-100LE in the Treatment of Multiple Myeloma
NCT00609817
Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia
NCT00514696
Study of LJP 394 in Lupus Patients With History of Renal Disease
NCT00089804
Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease
NCT00035308
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 6 |
| Phase 3 | 3 |
How the La Jolla Pharmaceutical Company early-phase archive is shaped
12 indexed studies, none listed as recruiting (0% open); 8 completed (67%).
Phase mix: 3 late (III/IV) vs 9 early (I/II) (early-phase heavy).
Therapeutic area indexing for this sponsor is limited in the public registry.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
La Jolla Pharmaceutical Company: archived-pipeline peers nationwide
Peers matched on 12 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
La Jolla Pharmaceutical Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 12 archived trials
- Alachua Government Services · 12 trials · 0% recruiting
- Allergy Therapeutics · 12 trials · 0% recruiting
- Ampio Pharmaceuticals. · 12 trials · 0% recruiting
- Angiodynamics · 12 trials · 17% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this La Jolla Pharmaceutical Company page
12 registered trials is a research-attention snapshot, not an endorsement of La Jolla Pharmaceutical Company or any single study.
- None of La Jolla Pharmaceutical Company's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. La Jolla Pharmaceutical Company pipeline card: 12 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.